SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-214151
Filing Date
2020-08-10
Accepted
2020-08-10 08:10:28
Documents
4
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d33966d8k.htm 8-K 16153
2 EX-99.1 d33966dex991.htm EX-99.1 20979
3 GRAPHIC g33966ex99logo001.jpg GRAPHIC 3961
4 GRAPHIC g33966ex99logo002.jpg GRAPHIC 2202
  Complete submission text file 0001193125-20-214151.txt   47058
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 201087195
SIC: 2836 Biological Products, (No Diagnostic Substances)